The evolution of thienopyridine therapy clopidogrel duration, diabetes, and drug-eluting stents.
about
Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialEstrogen-eluting stents.The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.Variability of clopidogrel response in patients with type 2 diabetes mellitus.
P2860
The evolution of thienopyridine therapy clopidogrel duration, diabetes, and drug-eluting stents.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@en
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@nl
type
label
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@en
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@nl
prefLabel
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@en
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@nl
P1476
The evolution of thienopyridin ...... etes, and drug-eluting stents.
@en
P2093
Anand Prasad
P304
P356
10.1016/J.JACC.2008.03.017
P407
P577
2008-06-01T00:00:00Z